Palette Life Sciences Revenue
Medical Equipment Manufacturing • 
Stockholm, Stockholm County, Sweden • 21-50 Employees
Palette Life Sciences revenue & valuation
| Annual revenue | $15,000,000 |
| Revenue per employee | $500,000 |
| Estimated valuation?This valuation is estimated based on industry average for the Medical Equipment Manufacturing industry and current estimated revenues | $48,000,000 |
| Total funding | $40,000,000 |
Key Contact at Palette Life Sciences
Cliff Kline
Director Of Clinical Affairs
Company overview
| Headquarters | Fogdevreten 2A 17165, Stockholm, Sweden, SE |
| Phone number | +46702120787 |
| Website | |
| NAICS | 3391 |
| Keywords | Urology, Prostate Cancer, Life Sciences, Medical Device, Oncology, Radiotherapy, Pediatric Urology, Colorectal Conditions, Urogynecology Disorders, Interventional Oncology Procedures |
| Founded | 2018 |
| Employees | 21-50 |
| Socials |
Palette Life Sciences Email Formats
Palette Life Sciences uses 2 email formats. The most common is {first initial}{last name} (e.g., jdoe@palettelifesciences.com), used 53.8% of the time.
| Format | Example | Percentage |
|---|---|---|
{first initial}{last name} | jdoe@palettelifesciences.com | 53.8% |
{first name}{last name} | johndoe@palettelifesciences.com | 46.2% |
About Palette Life Sciences
Palette Life Sciences is a fully integrated medical device company providing a wide range of products and services that improve quality of life of patients. Our portfolio of products focuses on treating conditions in urology/urogynecology disorders, colorectal conditions, radiotherapy, and interventional oncology procedures. For physicians, researchers, and inventors alike, progress begins with a natural curiosity and the drive to do more. By discovering and applying new applications of proven medicine to uncommon, or difficult to treat conditions, we can address the needs of patients often overlooked by traditional medical companies. Inspired by innovation and empathy, we see endless possibilities in expanding on proven technologies to elevate patient care. The foundation for all of our breakthrough products is Non-Animal Stabilized Hyaluronic Acid (NASHA®). NASHA has been proven safe and effective for more than two decades in over 50 million medical procedures worldwide. Barrigel® - the first and only FDA-cleared hyaluronic acid rectal spacer, minimizing the side effects of radiation therapy for prostate cancer patients. Barrigel is available in the US, Australia and Europe. Deflux® - the only FDA-approved injectable treatment for vesicoureteral reflux (VUR), a urinary defect that affects 1% of children worldwide. Deflux for VUR is available in the US, Canada, Europe, Japan, Latin America, Australia and New Zealand. Also indicated for stress urinary incontinence (SUI) in women, Deflux for SUI is available in Canada and Europe. Solesta® - the only FDA-approved injectable treatment for fecal incontinence, a debilitating health problem afflicting about 2% of people worldwide. Solesta is available in the US and Europe. Palette Life Sciences is headquartered in Stockholm, Sweden, with offices in Santa Barbara, California, Dallas, Texas, Sydney, Australia and Tokyo, Japan. Learn more at palettelifesciences.com.
Employees by Management Level
Total employees: 21-50
Seniority
Employees
Employees by Department
Palette Life Sciences has 9 employees across 4 departments.
Departments
Number of employees
Palette Life Sciences Tech Stack
Discover the technologies and tools that power Palette Life Sciences's digital infrastructure, from frameworks to analytics platforms.
Marketing automation
CDN
CDN
PaaS
CRM
JavaScript libraries
Tag managers
Hosting
Webmail
Miscellaneous
CDN
Analytics
France
Belgium
India
El Salvador
Norway
Frequently asked questions
4.8
40,000 users
